Omega Alpha SPAC
| General Information | |
| Business: | We intend to focus on the healthcare or healthcare-related industries, to capitalize on the expertise and capabilities of our management team in order to create long-term shareholder value. In particular, we expect to target North American or European companies in the biotechnology sector, where our management team has extensive investment experience. (Note: Omega Alpha SPAC’s IPO was an offering of Class A ordinary shares, not units. The typical SPAC IPO is a unit offering.) |
| Industry: | BLANK CHECKS |
| Employees: | 0 |
| Founded: | 2020 |
| Contact Information | |
| Address | 888 Boylston Street, Suite 1111 Boston, Massachusetts 02199 Tel.: (617) 502-6530888 Boylston Street, Suite 1111, Boston, MA 02199, US |
| Phone Number | |
| Web Address | |
| View Prospectus: | Omega Alpha SPAC |
| Financial Information | |
| Market Cap | $129.25mil |
| Revenues | $0 mil (last 12 months) |
| Net Income | $0 mil (last 12 months) |
| IPO Profile | |
| Symbol | OMEG |
| Exchange | NASDAQ |
| Shares (millions): | 12.0 |
| Price range | $10.00 - $10.00 |
| Est. $ Volume | $120.0 mil |
| Manager / Joint Managers | Jefferies/ Morgan Stanley |
| CO-Managers | - |
| Expected To Trade: | 1/7/2021 |
| Status: | Priced |
| Quiet Period Expiration Date: | Available only to Subscribers |
| Lock-Up Period Expiration Date: | Available only to Subscribers |
| SCOOP Rating | Available only to Subscribers |
| Rating Change | Available only to Subscribers |